Interim mid-stage data on Epizyme’s tazemetostat shows lower-than-expected response rate; shares down 17% premarket

from Stock Market News http://ift.tt/2s9WNBv’s-tazemetostat-shows-lower-than-expected-response-rate;-shares-down-17-premarket-495319

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s